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DEvolution in the management of the total thoracic aorta
Tad Kim, MD,a Tomas D. Martin, MD,a W. Anthony Lee, MD,b Philip J. Hess, Jr, MD,a Charles T. Klodell, MD,a
Curtis G. Tribble, MD,a Robert J. Feezor, MD,b and Thomas M. Beaver, MD, MPHa
Objectives: Extensive aneurysms of the ascending, arch, and descending thoracic aorta traditionally have been
managed with a 2-stage ‘‘elephant trunk’’ procedure. Single-stage transmediastinal repairs have also been used,
because in some patients the entire repair is not completed owing to either complications during first-stage repair
or magnitude of the second-stage operation. Since 2006, second-stage elephant trunks have been preferentially
completed with endovascular stent grafts in anatomically appropriate patients. This study compares outcomes
of 2-stage elephant trunk, single-stage, and hybrid endovascular repairs of extensive thoracic aortic aneurysms.
Methods: This is a single-institution retrospective cohort study of 103 patients (1992–2007) with extensive
thoracic aortic aneurysms undergoing 2-stage elephant trunk repair with either surgical (OPEN) or endovascular
(TEVAR) completion versus single-stage transmediastinal replacement (SS). Outcomes were analyzed with
Statistica 8.0 software (Tulsa, Okla).
Results: Of 103 patients, 74 had elephant trunk procedures, 24 TEVAR-eligible and 50 OPEN, and 29 had SS.
Completion rates were higher with TEVAR than OPEN (78% vs 47%; P ¼ .01). Seven of 18 TEVARs were
performed during the index hospitalization. TEVAR patients had shorter second-stage hospital stay (5.5 vs
16.5 days [P< .01]), required fewer transfusions (P< .01), and had less acute kidney injury (P ¼ .04). There
were no differences in mortality, paraplegia, or stroke. Six-month Kaplan–Meier survival estimates for OPEN,
TEVAR, and SS were 64%, 78%, and 64% (P ¼ .08).
Conclusion: More patients complete the second stage when TEVAR is used after elephant trunk repair, with
fewer hospital days and transfusions. TEVAR is feasible and safe in the hybrid management of extensive thoracic
aortic aneurysms.
ACQUIRED CARDIOVASCULAR DISEASEAExtensive thoracic aortic aneurysms, involving the ascend-
ing, arch, and descending thoracic aorta, are surgically chal-
lenging owing to both the extent of aortic involvement and
the morbidity and mortality associated with repair. In
1983, Borst, Walterbusch, and Schaps1 introduced the ‘‘ele-
phant trunk’’ technique, in which a segment of graft is left
suspended in the descending aorta to facilitate the second-
stage graft-to-graft anastomosis, typically performed 6 to 8
weeks after the first stage (Figure 1). While modifications
have been applied to this technique, it has become the main-
stay in the staged treatment of the total thoracic aorta. How-
ever, in up to 50% of patients, the second stage is never
completed owing to both the morbidity and mortality of
the first operation and to death from aneurysm rupture before
the second stage.2-4 Svensson and associates3 reported that
only 45% of patients underwent second-stage completion
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was only 34%. Safi and associates5 and Elefteriades6 re-
ported that 30% of patients who did not return for their sec-
ond-stage repair had died and that 30% of these deaths were
due to rupture of the untreated descending aneurysms.
Accordingly, we7 previously have reported our experience
with a single-stage transmediastinal replacement of the as-
cending, arch, and descending thoracic aorta (SS). In this op-
eration, the ascending aorta and proximal arch aorta are
repaired as in the standard first-stage elephant trunk opera-
tion, but a long segment of distal graft is anastomosed to
the descending aorta through a transmediastinal exposure
(Figure 1). Although completion rates were 100% with
this technique, morbidity and mortality were significant
with a 17% incidence of paraplegia and a 14% mortality
rate secondary to extended periods of circulatory arrest
and cardiopulmonary bypass (CPB).
In January 2005, the Food and Drug Administration ap-
proved the first commercially available thoracic endograft
(W. L. Gore TAG, Flagstaff, Ariz). By 2006, patients with
extensive thoracic aortic aneurysms were preferentially
treated with a first-stage elephant trunk operation followed
by second-stage thoracic endovascular aortic repair (TE-
VAR) in anatomically suitable candidates. We hypothesized
that this technique would improve completion rates and
early outcomes. The purpose of this report is to present
our concurrent series of evolving techniques for the treat-
ment of extensive thoracic aortic aneurysms and compare
outcomes among these three techniques.ardiovascular Surgery c Volume 137, Number 3 627
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DAbbreviations and Acronyms
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
MPSK ¼ combined incidence of mortality,
paraplegia, stroke, or kidney injury
OPEN ¼ open second-stage completion of
elephant trunk
OR ¼ odds ratio
RIFLE ¼ risk, injury, failure, loss, end-stage
classification for kidney injury
SS ¼ single-stage transmediastinal
replacement of the total thoracic aorta
TEVAR ¼ thoracic endovascular aneurysm repair
for second-stage completion
PATIENTS AND METHODS
Study Variables and Definitions
‘‘Acute’’ presentations involved emergency or urgent operations be-
cause of rupture, acute dissection, or symptoms. Extent of repair for the sec-
ond stage was based on Crawford’s classification. ‘‘Completion failure’’
was defined as death before the second stage, loss to follow-up, or failure
to treat the descending thoracic aortic aneurysm, except if the aneurysm
was less than 6 cm. Paraplegia included both transient and permanent def-
icits. Acute kidney injury was defined by RIFLE (Risk, Injury,Failure, Loss,
End-stage renal disease) injury score ‘‘I’’: serum creatinine twice the base-
line within 7 days postoperatively.8 Operative mortality included 30-day
and inpatient mortality. Gastrointestinal complications included visceral
ischemia, perforated viscus, or intestinal bleeding. This study was approved
by the Institutional Review Board of the University of Florida College of
Medicine.
Patients
The medical records of 103 consecutive patients with extensive thoracic
aortic aneurysms between 1992 and 2007 were retrospectively reviewed.
All patients underwent either single-stage transmediastinal replacement
(SS) or 2-stage elephant trunk repair, with either surgical (OPEN) or endo-
vascular (TEVAR) second-stage techniques. This represented an off-label
use of thoracic aortic endografts. Among the patients who underwent
a first-stage elephant trunk operation, all anatomically suitable or ‘‘TE-
VAR-eligible’’ patients were considered for endovascular repair and placed
in the TEVAR group. The rest were placed in the OPEN group.
Statistics
Completion rates and outcomes were analyzed for 3-way comparison by
Statistica 8.0 software (Statsoft Inc, Tulsa, Okla). Continuous variables
were expressed as means with standard deviation and analyzed by analysis
of variance, with the exception of hospital length of stay, time to comple-
tion, and follow-up period, which were expressed as medians with inter-
quartile ranges and analyzed by nonparametric analysis (Kruskal–Wallis
test). Categorical variables were expressed as proportions and compared
by Fisher’s exact significance test.
Kaplan–Meier survival analysis was performed by the Mantel–Cox log–
rank test. To compare survival among the three groups, we established a uni-
form cutoff time point at 6 months based on the group that first reached
a standard error greater than 10%. We used the Social Security Death Index
to note survivors to date.
Univariate analysis was performed by logistic regression to identify sta-
tistically significant predictors of outcomes.628 The Journal of Thoracic and Cardiovascular SurgOperative Details
Ascending and aortic arch operations were performed through a median
sternotomy. After systemic heparinization, arterial cannulation was per-
formed via the ascending aorta after epiaortic ultrasound (73%) or the fem-
oral artery or, more recently, the right axillary artery,9 and dual-stage venous
cannulas were placed in the right atrium. A vent was placed in the right
FIGURE 1. Illustration of the basic principle of the elephant trunk proce-
dure using an extension into the proximal descending thoracic aorta to
facilitate second-stage repair. Reprinted from Safi HJ, Miller CC 3rd,
Estrera AL, Huynh TT, Porat EE, Allen BS, et al. Staged repair of extensive
aortic aneurysms: long-term experience with the elephant trunk technique.
Ann Surg 2004;240:677-84; with permission.ery c March 2009
Kim et al Acquired Cardiovascular DiseaseFIGURE 2. Illustration of the single-stage transmediastinal replacement A, An incision is made in the posterior pericardium to expose the descending
thoracic aorta. A wire is passed into the arch to guide the graft down through the aorta and complete the distal anastomosis first. B, The ascending and
arch aorta are then repaired. Reprinted from Annals of Thoracic Surgery 72:1232-8, 2001. Beaver TM, Martin JD. Single-stage transmediastinal replacement
of the ascending arch, and desecending thoracic aorta; with permission from The Society of Thoracic Surgeons.A
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Dsuperior pulmonary vein on fibrillation. Retrograde cardioplegia was ad-
ministered in the coronary sinus and antegrade cardioplegia in the coronary
ostia. CPB was established and circulatory arrest was initiated at 18C on
electroencephalogram silence. For extended aortic arch reconstructions, ret-
rograde or antegrade cerebral perfusion was used on a case-by-case basis.10
SS was performed as previously described (Figure 2).7 Intercostal arteries
were excluded with this technique. First-stage elephant trunk procedures
were performed with modifications by Kusuhara, Shiraishi, and Iwakura.11
A transverse arch aortotomy was made, preserving an aortic island contain-
ing the great vessels, and an elephant trunk Dacron tube graft was placed in
the descending thoracic aorta (<10 cm). A portion of the graft was resected to
reimplant the aortic great vessels in a single anastomosis. The transverse arch
aortotomy was then closed around the graft. At this time, the graft was in-
verted and sewn to the aortic wall proximal to the arch vessels, sealing the
aorta around the graft. The graft was then unfolded, deaired, and the aortic
cannula was placed in the graft. The proximal graft was then anastomosed
to the ascending aorta. The patient was rewarmed and weaned from CPB.
For the second-stage OPEN procedure, the descending thoracic aneu-
rysm was approached through a left thoracotomy or thoracoabdominal
incision. Distal aortic perfusion strategies were used to reduce neurologic
complications.12 Formerly, left atrial–femoral artery partial bypass was
used, but now femoral artery–femoral vein bypass is preferentially used
with mesenteric perfusion. We routinely place cerebrospinal fluid drainage
catheters in the operating room for both OPEN and endovascular second-
stage repair (TEVAR) for prevention of spinal cord ischemia.13
Patients in the second-stage TEVAR group underwent computed tomo-
graphic imaging with 3-dimensional reconstruction to verify adequate prox-
imal and distal landing zones for stent-graft deployment and to determine
the appropriate sized endograft, typically 20% greater diameter. Using up
to 10 cm of elephant trunk graft typically provides a sufficient proximal
landing zone. During the procedure, guidewires were fluoroscopcally
guided into the elephant trunk. After systemic heparinization, an introducer
sheath was advanced, and the stent grafts were deployed. The proximal and
distal attachment sites and intervening junctions were ballooned to secure
the seal. Completion angiography was performed in all cases.
RESULTS
Between 1992 and 2007, 95 of 103 patients with exten-
sive thoracic aortic aneurysms underwent either an elephant
trunk operation with 43 intended surgical (OPEN) comple-
tions or 23 intended endovascular (TEVAR) completionsThe Journal of Thoracic andor 29 single-stage transmediastinal replacements (SS). Eight
patients (7 OPEN, 1 TEVAR) are currently being followed
up inasmuch as their descending thoracic aortic aneurysms
did not meet size criterion (6 cm) for repair, and these pa-
tients were excluded from completion rate calculation.
Demographics
Each group of patients represented different time periods
in the management of the total thoracic aorta. Accordingly,
some baseline characteristics were different among the three
groups: there were significantly more patients with aortic
dissections in the OPEN group and more patients with
both chronic lung disease and renal insufficiency in the
TEVAR group (Table 1).
Operative Characteristics
Forty-four percent of patients underwent a concomitant
aortic valve or root repair (Table 2). We have increasingly
used a valve-sparing procedure with external Dacron graft
support as previously described.14 Approximately one third
of patients underwent concomitant coronary artery bypass
grafting. Circulatory arrest time and retrograde cerebral per-
fusion time were significantly longer in the SS group com-
pared with both the OPEN and TEVAR groups.
Of the 38 patients who underwent second-stage repair
(20 OPEN and 18 TEVAR), 19 had purely descending tho-
racic aortic aneurysms, and 19 thoracoabdominal aortic
aneurysms, 10 of which were extent II (Table 3). During
the second-stage procedure, mean operating room time
with TEVAR completion was shorter than with OPEN com-
pletion (161 vs 308 minutes; P ¼ .0001).
Outcomes
For the entire series of 103 patients, the overall 30-day
and/or inpatient mortality rate was 18% (18/103) (Table 4).Cardiovascular Surgery c Volume 137, Number 3 629
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DFifty-four percent (56/103) were discharged home, and
28% (29/103) of patients were discharged to a rehabilitation
facility.
Of the 74 first-stage elephant trunk operations, 38% were
not followed by the second-stage repair (Table 5) because of
loss to follow-up (24%), first-stage death (8%), interim death
(4%), and too high risk for a second operation (1 patient, 1%).
Four patients received a ‘‘prophylactic’’ elephant trunk in
the event of a future descending thoracic aortic repair. One
was a 24-year-old patient with Marfan syndrome and no de-
scending aneurysm. Another had a ruptured ascending aneu-
rysm and no descending component. Two other patients had
descending aortas with maximum diameters of 2.0 cm and
3.5 cm.
The highest completion rate was with the single-stage (SS)
approach (100%), whereas among patients undergoing ele-
phant trunk repair, TEVAR completion (78.3%) was signif-
icantly higher than OPEN completion (46.5%) (P ¼ .01)
(Table 4). Seven of 18 TEVARs were performed during
the index hospitalization but as separate procedures. In the
patients undergoing elephant trunk repair, median second-
stage hospital stay was shorter with TEVAR (5.5 vs 16.5
days; P< .01). TEVAR patients required fewer intraopera-
tive blood transfusions, both overall and in the second stage
TABLE 1. Demographic variables of patients with extensive thoracic aortic aneurysms
Characteristics Total OPEN TEVAR SS P value
No. 103 50 24 29
Age (y) 65 (13) 64 (11) 65 (14) 66 (14) .85
Sex .82
Men 46 (45%) 22 (44%) 12 (50%) 12 (41%)
Women 57 (55%) 28 (56%) 12 (50%) 17 (60%)
Acute presentation 21 (20%) 12 (24%) 3 (13%) 6 (21%) .52
Aortic dissection 33 (32%) 23 (46%) 6 (25%) 4 (14%) .008
Acute 2 (2%) 1 (2%) 0 (0%) 1 (3%) .67
Chronic 31 (30%) 22 (44%) 6 (25%) 3 (10%) .005
Marfan syndrome 5 (5%) 2 (4%) 1 (4%) 2 (7%) .84
Previous sternotomy 33 (32%) 19 (38%) 8 (33%) 5 (17%) .16
Prior aortic procedure 37 (36%) 19 (38%) 10 (42%) 8 (28%) .53
Hypertension 85 (83%) 42 (84%) 20 (83%) 23 (79%) .87
Smoking 55 (53%) 28 (56%) 13 (54%) 14 (48%) .80
Diabetes 8 (8%) 2 (4%) 4 (17%) 2 (7%) .16
CAD 54 (52%) 23 (46%) 14 (58%) 17 (59%) .45
CLD 37 (36%) 18 (36%) 13 (54%) 6 (21%) .04
CRI 11 (11%) 4 (8%) 6 (25%) 1 (3%) .03
OPEN, Open second-stage completion of elephant trunk; TEVAR, thoracic endovascular aneurysm repair for second-stage completion; SS, single-stage transmediastinal replace-
ment of the total thoracic aorta; CAD, coronary artery disease; CLD, chronic lung disease; CRI, chronic renal insufficiency.
TABLE 2. Operative variables for elephant trunk (OPEN and TEVAR) and single-stage repairs of extensive aneurysms
Variable Total OPEN TEVAR SS P value
No. 103 50 24 29
Valve/root procedure 45 (44%) 25 (50%) 13 (54%) 7 (24%) .04
AV repair 21 (20%) 13 (26%) 5 (21%) 3 (10%) .29
Root 9 (9%) 5 (10%) 3 (13%) 1 (3%) .40
Valve sparing 6 (6%) 2 (4%) 2 (8%) 2 (7%) .64
AV replacement 9 (9%) 5 (10%) 3 (13%) 1 (3%) .39
CABG 35 (34%) 15 (30%) 7 (29%) 13 (45%) .36
Operative time (min) 509 (±205) 537 (±150) 419 (±144) .02
Stage I 385 (135) 411 (134) .44
Stage II 308 (±106) 161 (±78) .0001
Perfusion–ischemic times (min)
Circulatory arrest time 48 (±14) 44 (±12) 97 (±106) .0006
RCP time 34 (±17) 31 (±16) 57 (±24) .0001
Total CPB time 184 (58) 214 (72) 209 (82) .13
Cardiac ischemic time 107 (41) 104 (68) 117 (53) .57
OPEN, Open second-stage completion of elephant trunk; TEVAR, thoracic endovascular aneurysm repair for second-stage completion; SS, single-stage transmediastinal replace-
ment of the total thoracic aorta; AV, aortic valve; CABG, coronary artery bypass grafting; RCP, retrograde cerebral perfusion; CPB, cardiopulmonary bypass.
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acute kidney injury: 28%, 13%, and 41% for OPEN,
TEVAR, and SS. There were no significant differences
among the three groups in rates of 30-day/inpatient mortality,
paraplegia, or stroke. Median follow-up was 52, 17, and 71
months for OPEN, TEVAR, and SS. Kaplan–Meier esti-
mates of survival at 6 months were 64%, 78%, and 64%, re-
spectively, for the OPEN, TEVAR, and SS groups (P¼ .08).
Reoperation for bleeding was not significantly different:
8%, 8%, and 10% for OPEN, TEVAR, and SS (P ¼ .65).
Univariate Analysis
First-stage outcomes were analyzed in all 103 patients, in-
cluding those having single-stage repair, to find univariate
predictors of outcomes for ascending and arch replacements.
Univariate predictors for first-stage mortality were stroke
(odds ratio [OR] 7.8, 95% confidence intervals [CI] 1.4–
43.6), acute kidney injury (OR 13.4, 95% CI 3.7–47.8),
dialysis (OR 9.3, 95% CI 2.3–38.5), age (OR 1.3, 95% CI
1.1–1.4), CPB time (OR 1.3, 95% CI 1.1–1.6), and number
of intraoperative blood transfusions (OR 1.3, 95% CI 1.1–
1.6). The only predictor for first-stage acute kidney injury
was operative time (OR 1.2, 95% CI 1.0–1.5); and the
only predictor for first-stage paraplegia was prior abdominal
aortic aneurysm repair (OR 7.6, 95% CI 1.2–50.1). Univar-
iate predictors for the combined mortality/major morbidity
end point MPSK (defined as Mortality, Paraplegia, Stroke,
and acute Kidney injury) were operative time (OR 1.3,
95% CI 1.03–1.5), CPB time (OR 1.3, 95% CI 1.04–1.5),
and intraoperative transfusions (OR 1.3, 95% CI 1.1–1.6).
Univariate predictors for the 38 patients who underwent
the second-stage procedures were as follows: (1) acute kid-
ney injury: surgical technique (OR 4.9 for SS vs TEVAR,
95% CI 1.2–20.4), operative time (OR 1.7, 95% CI 1.3–
2.3), and intraoperative transfusions (OR 2, 95% CI 1.5–
2.5); (2) spinal cord ischemia: extent II thoracoabdominal
aortic aneurysm (OR 11.6, 95% CI 1–129) and operative
time (OR 1.6, 95% CI 1.2–2.1); and (3) MPSK: operative
time (OR 1.4, 95% CI 1.04–2.0), crossclamp time (OR
1.6, 95% CI 1.04–2.5), and intraoperative transfusions
(OR 1.5, 95% CI 1.1–2.1).
DISCUSSION
Repair of extensive thoracic aortic aneurysms poses a sig-
nificant surgical challenge, and alternative treatment options
are now available with endovascular techniques. Both sin-
gle-stage and 2-stage techniques have been described in
the literature, and novel hybrid techniques have been re-
cently introduced.
Proponents of a 2-stage technique believe that the morbid-
ity and mortality of replacing the entire thoracic aorta in one
stage are too high—17% in one report3 and 24% in our own
experience.7 Mortality rates of 8% for each stage have been
reported with the 2-stage approach.2,4 Borst’s elephant trunkThe Journal of Thoracic andtechnique obviates potentially hazardous dissection of the
aortic arch, with its associated risk of significant bleeding
or injury to the vagus and left recurrent laryngeal nerves.
Limiting the elephant trunk extension to no more than 10
to 15 cm is believed to reduce the risk of paraplegia.3
Kouchoukos and associates15 have used a bilateral anterior
thoracotomy incision in a single-stage approach with arch-
first anastomosis to decrease circulatory arrest times. Early
mortality rate was 7.2% with 5-year survival of 71% and
no perioperative strokes. The benefits of a single-stage re-
placement are that patients undergo treatment of the entire
thoracic aorta in one operation and avoid the risk of interval
rupture between stages. One limitation in both our own sin-
gle-stage series and also Kouchoukos’ series is that the aneu-
rysm can extend no further than the diaphragm. Furthermore,
our transmediastinal approach did not employ the arch-first
technique, which resulted in extended circulatory arrest times
and may have led to increased morbidity.16
Recently, hybrid endovascular approaches have been used
to treat extensive thoracic aortic aneurysms. Szeto and asso-
ciates17 reported using brachiocephalic bypass with stent
grafting of the arch for large aortic arch aneurysms. The
‘‘frozen elephant trunk,’’ which involves placement of a
stent in the descending aorta during arch replacement, was
reported by Baraki and coworkers18 with an early mortality
rate of 12.5% and stroke rate of 12.8%.
TEVAR completion of elephant trunks has been reported
by multiple centers, sometimes at the initial arch operation.19
Greenberg and colleagues20 reported a 30-day mortality of
4.5% in their series of 22 patients. The less-invasive endovas-
cular therapy increases the likelihood of completing the sec-
ond stage—a primary concern with staged approaches. Safi
and associates2 showed that patients may die of rupture
even within 6 weeks after first-stage repair and accordingly
shortened prior recommendations of second-stage repair to
4 weeks.
TABLE 3. Operative variables for second-stage OPEN versus TEVAR
Variable
Total
(n ¼ 38)
OPEN
(n ¼ 20)
TEVAR
(n ¼ 18)
P
value
Extent of repair
Descending only 19 (50%) 5 (25%) 14 (79%) .003
TAAA extent I 8 (21%) 6 (30%) 2 (11%) .24
TAAA extent II 10 (26%) 8 (40%) 2 (11%) .07
TAAA extent III 1 (2.6%) 1 (5%) 0 1.00
TAAA extent IV 0 0 0
CSF drainage in OR 27 (71%) 20 (100%) 7 (39%) 0
CSF drainage in ICU 1 (3%) 0 1 (6%) .47
Intercostal artery
reattachment
13 (65%)
Operative time (min) 308 (±106) 161 (±78) .0001
OPEN, Open second-stage completion of elephant trunk; TEVAR, thoracic endovascu-
lar aneurysm repair for second-stage completion; TAAA, thoracoabdominal aortic
aneurysm; CSF, cerebrospinal fluid; OR, operating room; ICU, intensive care unit.Cardiovascular Surgery c Volume 137, Number 3 631
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elephant trunk.21 Dislodgment of ‘‘peri–elephant trunk
thrombus’’ by guidewires during endovascular therapy can
result in thromboembolic consequences, as in 2 of our pa-
tients. One had mesenteric emboli, and the other had periph-
eral thromboembolism with foot necrosis. The risk of
perigraft thrombus may be reduced by earlier second-stage
repair, as advocated by Safi and colleagues.2 In fact, we
TABLE 4. Comparison of completion rates and outcome data for OPEN versus TEVAR versus SS
Overall OPEN TEVAR SS P value
No. 103 50 24 29
Follow-up (mo) 44 (22–74) 52 (38–79) 17 (12–28) 71 (34–86) .001
Completion* 67/95 (71%) 20/43 (47%) 18/23 (78%) 29/29 (100%) .02y
Completion time (d) 112 (58–276) 114 (74–190) 84 (16–441) — .52
Median LOS (d) 19 (13–31) 21 (13–33) 19 (14–27) 16 (9–29) .08
Stage I 13 (9–20) 12.5 (9–20) 15.5 (8–24) .19
Stage II 11 (6-20) 17 (12-25) 6 (4-10) .0001
Operative mortality 18 (18%) 7 (14%) 4 (17%) 7 (24%) .53
Stage I 7 (9%) 5 (10%) 2 (8%) 1.00
Stage II 4 (11%) 2 (10%) 2 (11%) 1.00
Paraplegia 10 (10%) 3 (6%) 2 (8%) 5 (17%) .23
Stage I 1 (1%) 0 1 (4%) .32
Stage II 4 (11%) 3 (15%) 1 (6%) .60
Stroke 8 (8%) 5 (10%) 1 (4%) 2 (6%) .89
Stage I 4 (5%) 3 (6%) 1 (4%) 1.00
Stage II 2 (5%) 2 (10%) 0 .49
AKI 29 (28%) 14 (28%) 3 (13%) 12 (41%) .04
Stage I 12 (16%) 9 (18%) 3 (13%) .74
Stage II 5 (13%) 5 (25%) 0 .048
MPSK 44 (43%) 19 (38%) 7 (29%) 18 (62%) .04
Stage I 33 (45%) 11 (22%) 4 (17%) .76
Stage II 11 (29%) 8 (40%) 3 (17%) .16
Tracheostomy 14 (14%) 6 (12%) 1 (4%) 7 (24%) .10
Stage I 6 (8%) 5 (10%) 1 (4%) .66
Stage II 1 (3%) 1 (5%) 0 1.00
Arrhythmias 38 (37%) 22 (44%) 11 (46%) 5 (17%) .03
Stage I 32 (43%) 21 (42%) 11 (46%) .81
Stage II 2 (5%) 2 (10%) 0 .49
Sternitis/mediastinitis 4 (4%) 3 (6%) 1 (4%) 0 .46
Reoperation for bleeding 9 (9%) 4 (8%) 2 (8%) 3 (10%) .91
Stage I 4 (5%) 3 (6%) 1 (4%) 1.00
Stage II 2 (5%) 1 (5%) 1 (6%) 1.00
Perioperative MI 1 (1%) 0 1 (4%) 0 .23
Stage I 1 (1%) 0 1 (4%) .32
Stage II 0 0 0
Pneumonia 19 (18%) 8 (16%) 1 (4%) 10 (34%) .02
Stage I 7 (9%) 6 (12%) 1 (4%) .42
Stage II 2 (5%) 2 (10%) 0 .49
GI complications 12 (10%) 3 (6%) 5 (21%) 4 (14%) .15
Stage I 5 (7%) 1 (2%) 4 (17%) .04
Stage II 5 (13%) 2 (10%) 3 (17%) .64
Multisystem failure 6 (6%) 2 (4%) 0 4 (14%) .09
Stage I 2 (3%) 2 (4%) 0 1.00
Stage II 0 0 0
Intraop PRBC (U) 6.2 (5.2) 7.2 (±6.1) 3.8 (±3.1) 6.2 (±4.1) .03
Stage I 4.1 (3.9) 4.7 (4.2) 3.0 (3.1) .09
Stage II 3.9 (4.9) 6.5 (±5.4) 1.0 (±1.6) .0002
OPEN, Open second-stage completion of elephant trunk; TEVAR, thoracic endovascular aneurysm repair for second-stage completion; SS, single-stage transmediastinal replace-
ment of the total thoracic aorta; LOS, length of stay; AKI, acute kidney injury; MPSK, incidence of operative Mortality, Paraplegia, Stroke, or acute Kidney injury; MI, myocardial
infarction; GI, gastrointestinal; PRBC, packed red blood cells. *Completion rates were calculated after exclusion of 7 patients from the OPEN group and 1 patient from the TEVAR
group who are actively being monitored. yP value relates to pairwise comparison between OPEN and TEVAR group.
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tion. Other technical modifications that have evolved over
time include marking the distal aspect of the endograft
with radiopaque surgical clips and snaring a guidewire intro-
duced through the right brachial artery to assist in the cath-
eterization of the elephant trunk.20,22
Patients assigned to the TEVAR group may have inher-
ently been at lower risk, by way of being ‘‘anatomically
eligible’’ for TEVAR and having less complex aneurysms
that did not involve the visceral vessels. Four of our TEVAR
patients had thoracoabdominal aortic aneurysms (2 extent I
and 2 extent II aneurysms). One patient with extent I thora-
coabdominal aortic aneurysm underwent TEVAR to cover
the entire descending thoracic aorta, leaving a small segment
of aneurysm in the supraceliac aorta; follow-up computed
tomography at 1 month showed a stable descending aorta di-
ameter. Another patient with extent II thoracoabdominal
aortic aneurysm was treated similarly, leaving a smaller
4.3-cm aneurysm from the supraceliac aorta to down below
the renals. The other patient with extent I thoracoabdominal
aortic aneurysm had an external Dacron wrap of the supra-
celiac aorta to create a suitable landing zone. We23 have
used this technique in patients with large-neck aneurysms
and with endoleaks after TEVAR. The final patient with ex-
tent II thoracoabdominal aortic aneurysm had a suitable
landing zone only in the infrarenal aorta and aneurysmal in-
volvement of all visceral vessels. She underwent a mesen-
teric/renal revascularization from the right common iliac
artery using a bifurcated Dacron graft and was subsequently
covered with stent grafts down to the bifurcation. Lee and
colleagues24 published early results of similar staged hybrid
repairs of thoracoabdominal aortic aneurysm involving vis-
ceral and/or renal vessels in 17 patients. These patients had
extensive comorbidities precluding an open approach, and
operative mortality was significant at 24%.
There are several limitations of the current study. It is a ret-
rospective study with an inherent selection bias. There is
also potential for bias owing to interactions between our out-
comes and time period. We analyzed our data for interac-
tions between mortality, stroke, or MPSK and time period
but found no significant interactions (data not shown).
Also, given the relatively recent implementation of TEVAR,
TABLE 5. Completion failures among elephant trunk patients
Total
(n ¼ 74)
OPEN
(n ¼ 50)
TEVAR
(n ¼ 24)
Total first-stage only 36 (48.6%) 30 (60%) 6 (25%)
Active follow-up 8 (10.8%) 7 (14%) 1 (4.2%)
Completion failures* 28 (37.8%) 23 (46%) 5 (20.8%)
*Reasons for completion failure
No follow-up 18 (24.3%) 17 (34%) 1 (4.2%)
First-stage death 6 (8.1%) 4 (8%) 2 (8.3%)
Interim death 3 (4.1%) 1 (2%) 2 (8.3%)
Too high risk 1 (1.4%) 1 (2%) 0The Journal of Thoracic and Cfollow-up for this group was shorter. Long-term follow-up
will be required to monitor for endoleaks and the stability
of the surgical graft–endograft junction. Nonetheless, TE-
VAR is less invasive and short-term results are acceptable.
CONCLUSION
In conclusion, this study reports a concurrent series of
three techniques that have evolved over 15 years in a single
institution for the treatment of extensive thoracic aortic an-
eurysms. In anatomically suitable candidates, TEVAR has
become our preferred approach in the management of com-
plex thoracic aortic aneurysms.
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